Literature DB >> 22434421

Prediction of the histopathological grade of hepatocellular carcinoma using qualitative diffusion-weighted, dynamic, and hepatobiliary phase MRI.

Chansik An1, Mi-Suk Park, Hyae-Min Jeon, Yeo-Eun Kim, Woo-Suk Chung, Yong Eun Chung, Myeong-Jin Kim, Ki Whang Kim.   

Abstract

OBJECTIVES: To investigate the effectiveness of qualitative diffusion-weighted imaging (DWI), subtraction of unenhanced from arterial phase images, and hepatobiliary phase (HBP) images in estimating the histopathological grade of hepatocellular carcinoma (HCC).
METHODS: We retrospectively reviewed gadoxetic acid-enhanced magnetic resonance images of 175 patients with 201 surgically resected HCCs. The signal intensity and its relationship with histopathological grade were assessed for each sequence and a combination of sequences.
RESULTS: There was a tendency towards higher grades in tumours showing restricted diffusion on DWI (P < 0.001) or arterial enhancement on subtraction imaging (P < 0.001), but not hepatocyte-defect on HBP images (P = 0.33). When lesions were divided into three groups based on combined findings on DWI and subtraction imaging, a linear trend was observed between group and grade (P < 0.001). The positive predictive value (PPV) of the combination of no restricted diffusion and no arterial enhancement in predicting well-differentiated HCC was 100%, higher than the PPV of individual findings on DWI (74%) or subtraction imaging (81%).
CONCLUSIONS: DWI and subtraction imaging are helpful for predicting the histopathological grade of HCC, especially when the two sequences are considered together. KEY POINTS: • Predicting the histopathological grade of hepatocellular carcinoma (HCC) preoperatively is important. • Diffusion-weighted imaging (DWI) and subtraction imaging are recently developed MR techniques. • Retrospective study showed DWI and subtraction imaging helps predict HCC grades. • Management of patients with HCC becomes more appropriate.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22434421     DOI: 10.1007/s00330-012-2421-6

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  18 in total

1.  Diagnostic performance of apparent diffusion coefficient for predicting histological grade of hepatocellular carcinoma.

Authors:  Akihiro Nishie; Tsuyoshi Tajima; Yoshiki Asayama; Kousei Ishigami; Daisuke Kakihara; Tomohiro Nakayama; Yukihisa Takayama; Daisuke Okamoto; Nobuhiro Fujita; Akinobu Taketomi; Kengo Yoshimitsu; Hiroshi Honda
Journal:  Eur J Radiol       Date:  2010-07-08       Impact factor: 3.528

2.  Dynamic subtraction magnetic resonance imaging of cirrhotic liver: assessment of high signal intensity lesions on nonenhanced T1-weighted images.

Authors:  Jeong-Sik Yu; Young Hwan Kim; Neil M Rofsky
Journal:  J Comput Assist Tomogr       Date:  2005 Jan-Feb       Impact factor: 1.826

3.  Arterial blood supply of hepatocellular carcinoma and histologic grading: radiologic-pathologic correlation.

Authors:  Yoshiki Asayama; Kengo Yoshimitsu; Yunosuke Nishihara; Hiroyuki Irie; Shinichi Aishima; Akinobu Taketomi; Hiroshi Honda
Journal:  AJR Am J Roentgenol       Date:  2008-01       Impact factor: 3.959

4.  Clinicopathologic features of poorly differentiated hepatocellular carcinoma.

Authors:  Koichi Oishi; Toshiyuki Itamoto; Hironobu Amano; Saburo Fukuda; Hideki Ohdan; Hirotaka Tashiro; Fumio Shimamoto; Toshimasa Asahara
Journal:  J Surg Oncol       Date:  2007-03-15       Impact factor: 3.454

5.  Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow.

Authors:  Sachiyo Kogita; Yasuharu Imai; Masahiro Okada; Tonsok Kim; Hiromitsu Onishi; Manabu Takamura; Kazuto Fukuda; Takumi Igura; Yoshiyuki Sawai; Osakuni Morimoto; Masatoshi Hori; Hiroaki Nagano; Kenichi Wakasa; Norio Hayashi; Takamichi Murakami
Journal:  Eur Radiol       Date:  2010-05-19       Impact factor: 5.315

6.  Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis.

Authors:  S Jonas; W O Bechstein; T Steinmüller; M Herrmann; C Radke; T Berg; U Settmacher; P Neuhaus
Journal:  Hepatology       Date:  2001-05       Impact factor: 17.425

7.  Histopathologic differentiation of the main nodule determines outcome after hepatic resection for synchronous multicentric hepatocellular carcinomas.

Authors:  Shun-ichi Ariizumi; Ken Takasaki; Masakazu Yamamoto; Takehito Ohtsubo; Hideo Katsuragawa; Satoshi Katagiri
Journal:  Hepatogastroenterology       Date:  2004 Mar-Apr

8.  Apparent diffusion coefficient value of diffusion-weighted imaging for hepatocellular carcinoma: correlation with the histologic differentiation and the expression of vascular endothelial growth factor.

Authors:  Suk Hee Heo; Yong Yeon Jeong; Sang Soo Shin; Jin Woong Kim; Hyo Soon Lim; Jae Hyuk Lee; Yang Seok Koh; Chol Kyoon Cho; Heoung Keun Kang
Journal:  Korean J Radiol       Date:  2010-04-29       Impact factor: 3.500

9.  Tumor recurrence after liver transplantation for hepatocellular carcinoma: recurrence pathway and prognostic factors.

Authors:  B Pérez-Saborido; S Jiménez de los Galanes; J C Menéu-Díaz; C Jiménez Romero; A Moreno Elola-Olaso; Y Fundora Suárez; V Barra Valencia; E Moreno-González
Journal:  Transplant Proc       Date:  2007-09       Impact factor: 1.066

10.  The role of dynamic subtraction MRI in detection of hepatocellular carcinoma.

Authors:  Mustafa Seçil; Funda Obuz; Canan Altay; Omür Gencel; Enis Iğci; Ozgül Sağol; Oğuz Dicle
Journal:  Diagn Interv Radiol       Date:  2008-12       Impact factor: 2.630

View more
  21 in total

Review 1.  Appearance of hepatocellular carcinoma on gadoxetic acid-enhanced hepato-biliary phase MR imaging: a systematic review.

Authors:  Paola Erra; Marta Puglia; Alfonso Ragozzino; Simone Maurea; Raffaele Liuzzi; Giuseppe Sabino; Luigi Barbuto; Alberto Cuocolo; Massimo Imbriaco
Journal:  Radiol Med       Date:  2015-04-22       Impact factor: 3.469

Review 2.  Added value of diffusion-weighted acquisitions in MRI of the abdomen and pelvis.

Authors:  William A Moore; Gaurav Khatri; Ananth J Madhuranthakam; Robert D Sims; Ivan Pedrosa
Journal:  AJR Am J Roentgenol       Date:  2014-05       Impact factor: 3.959

3.  Prediction of histological grade of hepatocellular carcinoma using quantitative diffusion-weighted MRI: a retrospective multivendor study.

Authors:  Yusuke Ogihara; Yoshio Kitazume; Yoshihiro Iwasa; Shinichi Taura; Yoshiro Himeno; Tomo Kimura; Seishi Sawano; Shigehiko Terada; Minoru Tanabe; Yukihisa Saida; Ukihide Tateishi
Journal:  Br J Radiol       Date:  2018-02-05       Impact factor: 3.039

4.  Pre-operative ADC predicts early recurrence of HCC after curative resection.

Authors:  Sunyoung Lee; Seong Hyun Kim; Jeong Ah Hwang; Ji Eun Lee; Sang Yun Ha
Journal:  Eur Radiol       Date:  2018-07-19       Impact factor: 5.315

Review 5.  Prognostication and response assessment in liver and pancreatic tumors: The new imaging.

Authors:  Riccardo De Robertis; Paolo Tinazzi Martini; Emanuele Demozzi; Gino Puntel; Silvia Ortolani; Sara Cingarlini; Andrea Ruzzenente; Alfredo Guglielmi; Giampaolo Tortora; Claudio Bassi; Paolo Pederzoli; Mirko D'Onofrio
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

Review 6.  New paradigm for management of hepatocellular carcinoma by imaging.

Authors:  Ijin Joo; Byung Ihn Choi
Journal:  Liver Cancer       Date:  2012-09       Impact factor: 11.740

Review 7.  JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan.

Authors:  Masatoshi Kudo; Osamu Matsui; Namiki Izumi; Hiroko Iijima; Masumi Kadoya; Yasuharu Imai; Takuji Okusaka; Shiro Miyayama; Kaoru Tsuchiya; Kazuomi Ueshima; Atsushi Hiraoka; Masafumi Ikeda; Sadahisa Ogasawara; Tatsuya Yamashita; Tetsuya Minami; Koichiro Yamakado
Journal:  Liver Cancer       Date:  2014-10       Impact factor: 11.740

Review 8.  CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features.

Authors:  Jin-Young Choi; Jeong-Min Lee; Claude B Sirlin
Journal:  Radiology       Date:  2014-10       Impact factor: 11.105

9.  Added value of subtraction imaging in detecting arterial enhancement in small (<3 cm) hepatic nodules on dynamic contrast-enhanced MRI in patients at high risk of hepatocellular carcinoma.

Authors:  Chansik An; Mi-Suk Park; Dowhan Kim; Yeo-Eun Kim; Woo-Suk Chung; Hyungjin Rhee; Myeong-Jin Kim; Ki Whang Kim
Journal:  Eur Radiol       Date:  2012-11-09       Impact factor: 5.315

10.  New MRI series for kidney evaluation: Saving time and money.

Authors:  Matteo Renzulli; Stefano Brocchi; Irene Pettinari; Maurizio Biselli; Alfredo Clemente; Beniamino Corcioni; Salvatore Cappabianca; Caterina Gaudiano; Rita Golfieri
Journal:  Br J Radiol       Date:  2019-06-12       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.